Launch of Evo Visian® ICL in the US; an evolutionary – Tips & Results

CHINO, Calif., April 27, 2022 (GLOBE NEWSWIRE) — EVO Visian® ICL (“EVO”) is an evolutionary, clinically proven implantable lens that corrects common vision problems such as myopia and myopia with astigmatism. With over 1 million EVO lenses implanted worldwide, EVO Visian ICL is now FDA cleared in the United States and may offer a new solution for those seeking sharp, clear vision and wanting to free themselves from the inconvenience of contact lenses or eyeglasses.EVO is now available from Coastal Vision Medical Group, making it one of the first eye care practices in Orange County, LA County and the Inland Empire to offer this groundbreaking vision correction process.

“We are excited to offer our patients this new FDA-cleared technology. The latest generation of Visian technology, the Evo Visian ICL, offers a simple procedure, recovery and superior optical results compared to previous generations of this type of Visian technology,” said Coastal Vision founder Dan B. Tran, MD “Our practice has over 16 years of experience with phakic IOL technology. I was one of the first surgeons in the US to correct patients’ vision with phakic IOL technology and was involved in clinical trials before the Technology was FDA approved in the US in 2005. I am pleased to offer my patients the EVO lens because it provides sharp, clear vision, excellent night vision and UV protection without causing dry eye syndrome or corneal tissue need to be removed. The EVO procedure is a 20-30 minute outpatient procedure with a rapid recovery and typically little downtime, and many patients bemer Immediate improvement in vision after the procedure.”

The EVO Visian ICL lens is slightly smaller than a typical contact lens and is implanted in the eye between the iris (colored part of the eye) and the natural lens to improve vision. The EVO lens differs from other vision correction options like LASIK performed by ophthalmologists because it is additive; That means it is implanted in the eye and does not involve the removal of corneal tissue. The EVO lens works in harmony with the natural eye, providing sharp, clear vision, excellent night vision and UV protection. In addition, the EVO lens does not cause dry eye syndrome. While the EVO Visian ICL lens is new to the US market, over 1,000,000 EVO ICL lenses have been implanted in Europe, Asia and other locations around the world.

“The EVO procedure changed my life,” said Dr. Kathryn Pham, an Orange County optometrist and Coastal Vision patient. “I have struggled with wearing contacts and glasses for most of my life and was not a good candidate for LASIK. The ICL procedure was quick and I could see clearly straight away. I would recommend this procedure to anyone who wants to go without glasses or contacts.” Watch the video by Dr. Kathryn Pham at

Myopia (or nearsightedness) is the most common eye disease worldwide and its prevalence is increasing rapidly. An estimated 30% of the world’s population, or 2.6 billion people, have myopia and this number is projected to increase to 50% of the world’s population by 2050. Offering an EVO Visian ICL lens can permanently correct vision without removing corneal tissue and can be made reversible by a doctor if desired for added peace of mind. It gives the patient flexibility for the future while helping to eliminate dependency on glasses and contact lenses now. Visit for more information.

About the Coastal Vision Medial Group

Founded in 1999, Coastal Vision Medical Group is a physician-owned premier provider of eye care with multiple locations in Orange County, Los Angeles County and the Inland Empire. We have four eye clinics with locations in Orange, Irvine, Long Beach and Chino (adjacent to Chino Hills). Our surgeons are highly qualified and experienced in LASIK, cataract surgery, glaucoma treatment and other general ophthalmic conditions. Coastal Vision’s surgeons and optometrists actively participate in FDA ophthalmic clinical trials to further expand future medical and surgical offerings. These options can often be made available to our patients earlier in clinical trials.

Our mission is to provide our patients with the best possible medical and surgical ophthalmic care using the latest and best technology available.

# # #

Media contact:

Gina Waldemar
Director, Marketing & Business Development
Phone: (888) 501-4496

Mailing address: 14726 Ramona Ave Ste 200, Chino, CA 91710

Related Images

Image 1: Get rid of glasses and contact with EVO’s implantable collamer lens

Image of the EVO Implantable ICL Lens preceded by the following text: Break Free from Glasses & Contact with the EVO Implantable Collamer Lens

This content was distributed via’s press release distribution service.

  • Free yourself from glasses and contact with EVO’s implantable collamer lens

Leave a Comment